Drug Type Small molecule drug |
Synonyms Malol, Prunol, Urson + [2] |
Target |
Mechanism Enzymes inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H48O3 |
InChIKeyWCGUUGGRBIKTOS-GPOJBZKASA-N |
CAS Registry77-52-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Ursolic Acid | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 2 | CN | 04 May 2023 | |
Advanced Hepatocellular Carcinoma | Phase 2 | CN | 04 May 2023 | |
Metabolic Syndrome | Phase 2 | MX | 01 Sep 2014 | |
Breast Cancer | Phase 1 | CN | 16 Sep 2009 | |
Colonic Cancer | Phase 1 | CN | 16 Sep 2009 | |
Lung Cancer | Phase 1 | CN | 16 Sep 2009 | |
Pancreatic Cancer | Phase 1 | CN | 16 Sep 2009 | |
Stomach Cancer | Phase 1 | CN | 16 Sep 2009 |
Not Applicable | - | pzknszioco(oxpkvfconu) = zpxxeqqiin kfpkodmedb (rdywhwyzny ) View more | Positive | 15 Oct 2022 | |||
Phase 2/3 | - | (UA supplementation) | gcjdjqnwwl(rttkiceszu) = rmijujwpnt xlcanqyytm (jpvxngpegd ) | Negative | 01 Aug 2021 | ||
(Placebo supplementation) | - | ||||||
Phase 2 | 24 | (Ursolic Acid) | gxbsvykwck(ikvebfygxb) = yrsznnddgc xojrdbtoxe (bbrymcwlkh, cgoqokuatj - uoupmjczcp) View more | - | 08 Oct 2020 | ||
Placebo (Placebo) | gxbsvykwck(ikvebfygxb) = jxciffoylr xojrdbtoxe (bbrymcwlkh, iwagyqejbu - ypjhaquial) View more | ||||||
Not Applicable | - | ipwozswpda(cjwaflnlnd) = kuksjoladh ooozdspxza (ecowdcjrzh ) | - | 01 Jul 2017 | |||
Not Applicable | - | Ursolic acid (UA) | oaqpubrkbj(zhnrwurbvi) = the mRNA expression of markers associated with B cell activation (Bcl-6), plasma cell differentiation (Blimp-1) and isotype switching (activation-induced deaminase) was markedly reduced with UA treatment vxomfjafbk (yemxgmorjx ) View more | - | 11 Jun 2014 |